[Guillain-Barré syndrome].

By J. Raphaël. La Revue du praticien, 2005

3,499 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/27fdba9da2ffef68dee422c1cd9d37f703914632

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Michael S. Diamond
2. Helen M. Lazear
3. F. Costa
4. Jonathan J. Miner
5. David K. Shay
6. Anthony E. Fiore
7. Jennifer Govero
8. A. Smith

Citations in the corpus

• Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. (2014, background): “Recent studies indicate that Guillain-Barré syndrome consists of a spectrum of neuropathic disorders that may differ in the underlying pathogenesis and clinical manifestations (Yuki and Hartung, 2012).”
• A Mouse Model of Zika Virus Pathogenesis (2016, background): “temporary, GBS-induced respiratory paralysis can be fatal (Willison et al., 2016).”
• Sialic acids in human health and disease (2008, unknown): “Guillian-Barré syndrome (an acute generalized peripheral neuropathy) is often triggered by intestinal infections with Camplyobacter jejuni, which synthesizes sialylated mimics of neural gangliosides on its lipooligosaccharides [123,124].”
• Sialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regeneration. (2014, background): “Guillain-Barré syndromes (GBS) are the leading cause of acute neuromuscular paralysis, with 75,000 cases per year worldwide (206, 499, 577).”
• Population Incidence of Guillain-Barré Syndrome: A Systematic Review and Meta-Analysis (2011, unknown): “…syndrome (GBS) is a condition characterized by the acute or subacute onset of varying degrees of weakness in limbs or cranial nerve-innervated muscles, associated decreased or absent deep tendon reflexes, and a characteristic profile in the cerebrospinal fluid and electrodiagnostic studies [1].”
• Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. (2009, background): “Two studies showed that persons who had symptoms of ORS after TIV were at a higher risk for ORS after subsequent TIV administration; however, these events usually were milder than the first episode (230,231).”
• Zika virus: History, emergence, biology, and prospects for control. (2016, background): “The onset of GBS presumably involves an autoimmune process (Yuki and Hartung, 2012), but the underlying factors that influence the association of GBS and ZIKV infection have not yet been determined.”